Immunotherapy against glioblastoma using backpack‐activated neutrophils

Immunotherapy against glioblastoma using backpack‐activated neutrophils

Abstract Immune checkpoint inhibitors (ICIs) represent new therapeutic candidates against glioblastoma multiforme (GBM); however, their efficacy is clinically limited due to both local and systemic immunosuppressive environments. Hence, therapeutic approaches that stimulate local and systemic immune...

Full description

Saved in:
Bibliographic Details
Main Authors: Tatsuya Fukuta, Ninad Kumbhojkar, Supriya Prakash, Suyog Shaha, A. Da Silva‐Candal, Kyung Soo Park, Samir Mitragotri
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:Bioengineering & Translational Medicine
Subjects:
cell therapy
glioblastoma
immune checkpoint inhibitor
immunotherapy
neutrophils
Online Access:https://doi.org/10.1002/btm2.10712
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/btm2.10712

Similar Items